News

AMN vs. PGNY: Which Stock Should Value Investors Buy Now?

  • AMN vs. PGNY: Which Stock Is the Better Value Option?
    08/08/2022

Progyny, Inc. (PGNY) CEO Peter Anevski on Q2 2022 Results - Earnings Call Transcript

  • Progyny, Inc. (NASDAQ:PGNY ) Q2 2022 Earnings Conference Call August 4, 2022 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Sarah James - Barclays Stephanie Davis - SVB Securities Dev Weerasuriya – Berenberg Capital Markets Operator Good afternoon, ladies and gentlemen, and welcome to today's Progyny Inc. Second Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode.
    08/07/2022
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Progyny, Inc. (PGNY) can buy. Click on Rating Page for detail.

The price of Progyny, Inc. (PGNY) is 45.4 and it was updated on 2022-08-17 01:53:39.

Currently Progyny, Inc. (PGNY) is in overvalued.

News
    
News

Progyny Stock Should Deliver Superior Returns For Investors

  • More companies in the U.S. are offering fertility benefits to employees to attract/retain talent and advance the diversity, equity, and inclusion agenda. PGNY has singled itself out as a pure-play fertility benefits management company, building an enviable client roster with 273 clients representing 30+ industries.
    Fri, Aug. 05, 2022

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

  • Progyny (PGNY) delivered earnings and revenue surprises of 350% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
    Thu, Aug. 04, 2022

Why This Company Still Has a Long Runway for Growth

  • A competitive labor landscape makes this company's offerings even more attractive.
    Wed, Jul. 13, 2022

Progyny: Solving Infertility Problem

  • Progyny is a leading benefit management company that specializes in fertility and family building. Their revenue has been growing at an amazing pace (80% per year, 5 year average).
    Tue, Jul. 05, 2022

AMN or PGNY: Which Is the Better Value Stock Right Now?

  • AMN vs. PGNY: Which Stock Is the Better Value Option?
    Fri, Jun. 10, 2022
SEC Filings
SEC Filings

Progyny, Inc. (PGNY) - DEFA14A

  • SEC Filings
  • 04/14/2022

Progyny, Inc. (PGNY) - DEF 14A

  • SEC Filings
  • 04/14/2022

Progyny, Inc. (PGNY) - S-8

  • SEC Filings
  • 03/02/2022

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 02/14/2022

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/14/2022

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 02/11/2022

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/10/2022

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/04/2022

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 05/10/2021

Progyny, Inc. (PGNY) - DEFA14A

  • SEC Filings
  • 04/22/2021

Progyny, Inc. (PGNY) - DEF 14A

  • SEC Filings
  • 04/22/2021

Progyny, Inc. (PGNY) - SC 13D

  • SEC Filings
  • 03/02/2021

Progyny, Inc. (PGNY) - S-8

  • SEC Filings
  • 03/02/2021

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 02/16/2021

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/16/2021

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 02/12/2021

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/12/2021

Progyny, Inc. (PGNY) - SC 13G/A

  • SEC Filings
  • 02/04/2021

Progyny, Inc. (PGNY) - DEFA14A

  • SEC Filings
  • 04/22/2020

Progyny, Inc. (PGNY) - DEF 14A

  • SEC Filings
  • 04/22/2020

Progyny, Inc. (PGNY) - S-8

  • SEC Filings
  • 03/11/2020

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/14/2020

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/13/2020

Progyny, Inc. (PGNY) - SC 13G

  • SEC Filings
  • 02/11/2020

Progyny, Inc. (PGNY) - 3/A

  • SEC Filings
  • 01/24/2020

Progyny, Inc. (PGNY) - S-8

  • SEC Filings
  • 10/25/2019

Progyny, Inc. (PGNY) - 424B4

  • SEC Filings
  • 10/25/2019

Progyny, Inc. (PGNY) - EFFECT

  • SEC Filings
  • 10/24/2019

Progyny, Inc. (PGNY) - CERT

  • SEC Filings
  • 10/24/2019

Progyny, Inc. (PGNY) - CORRESP

  • SEC Filings
  • 10/22/2019

Progyny, Inc. (PGNY) - 8-A12B

  • SEC Filings
  • 10/22/2019

Progyny, Inc. (PGNY) - S-1/A

  • SEC Filings
  • 10/15/2019

Progyny, Inc. (PGNY) - CORRESP

  • SEC Filings
  • 10/15/2019

Progyny, Inc. (PGNY) - CORRESP

  • SEC Filings
  • 10/04/2019

Progyny, Inc. (PGNY) - UPLOAD

  • SEC Filings
  • 10/02/2019

Progyny, Inc. (PGNY) - S-1

  • SEC Filings
  • 09/27/2019

Progyny, Inc. (PGNY) - DRSLTR

  • SEC Filings
  • 09/24/2019

Progyny, Inc. (PGNY) - UPLOAD

  • SEC Filings
  • 09/20/2019

Progyny, Inc. (PGNY) - DRSLTR

  • SEC Filings
  • 09/11/2019

Progyny, Inc. (PGNY) - DRS/A

  • SEC Filings
  • 09/11/2019

Progyny, Inc. (PGNY) - UPLOAD

  • SEC Filings
  • 08/26/2019

Progyny, Inc. (PGNY) - DRS

  • SEC Filings
  • 08/02/2019

Progyny, Inc. (PGNY) - D

  • SEC Filings
  • 06/29/2016

Progyny, Inc. (PGNY) - D

  • SEC Filings
  • 03/19/2015

Progyny, Inc. (PGNY) - D

  • SEC Filings
  • 09/16/2013

Progyny, Inc. (PGNY) - D

  • SEC Filings
  • 07/30/2013

Progyny, Inc. (PGNY) - D

  • SEC Filings
  • 06/04/2012
Press Releases
StockPrice Release
More Headlines
News

Progyny, Inc. to Present at the Jefferies 2022 Healthcare Conference

  • NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies 2022 Healthcare Conference on Wednesday, June 8, 2022 at 10:30 A.M. Eastern Time.
  • 06/01/2022

Progyny Stock: A Hidden Gem Tackling Infertility

  • Progyny is a hidden gem tackling a prevalent and growing issue. With massive growth ahead and a solid competitive position, Progyny is a great addition to your portfolio.
  • 05/31/2022

AMN vs. PGNY: Which Stock Is the Better Value Option?

  • AMN vs. PGNY: Which Stock Is the Better Value Option?
  • 05/25/2022

Progyny, Inc. (PGNY) CEO Peter Anevski on Q1 2022 Results - Earnings Call Transcript

  • Progyny, Inc. (NASDAQ:PGNY ) Q1 2022 Earnings Call Transcript May 5, 2022 5:00 PM ET Company Representatives Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer James Hart - Vice President of Investor Relations Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Bank of America Sarah James - Barclays Glen Santangelo - Jefferies Stephanie Davis - SVB Securities Dev Weerasuriya - Berenberg Operator Good afternoon, ladies and gentlemen, and welcome to the Progyny Inc. First Quarter 2022 Earnings Conference Call. At this time, all participants have been on a listen-only mode and the floor will be opened for questions and comments after the presentation.
  • 05/05/2022

Progyny: A Profitable High-Growth Company

  • Incorporated in 2008, Progyny Inc. ( PGNY , Financial) is a leading benefits management company operating in the fertility space in the United States. The company operates as a third-party insurance company that manages fertility benefit plans, and the most famous product sold by the company is Smart Cycle.
  • 05/04/2022

Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference

  • NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced executives from Progyny will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 11:40 A.M. Eastern Time, or 8:40 A.M. Pacific Time.
  • 04/28/2022

AVTR vs. PGNY: Which Stock Is the Better Value Option?

  • AVTR vs. PGNY: Which Stock Is the Better Value Option?
  • 04/11/2022

2 No-Brainer Stocks to Buy Right Now for Less than $55

  • These two healthcare companies have bright futures -- and right now, two-digit price tags.
  • 04/05/2022

Investors see growth opportunity in Femtech

  • Funding for so-called Femtech has more than tripled since 2015. Early stage investors see growth opportunities in companies like breast cancer imaging start-up Clairity, which are looking to close the gap on women's health issues.
  • 03/21/2022

OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?

  • OCDX vs. PGNY: Which Stock Is the Better Value Option?
  • 03/15/2022

Progyny, Inc. to Present at the Barclays Global Healthcare Conference

  • NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 15, 2022 at 3:50 P.M. Eastern Time.
  • 03/10/2022

Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript

  • Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript
  • 02/28/2022

Progyny (PGNY) Surpasses Q4 Earnings Estimates

  • Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 02/28/2022

Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

  • NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny's Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 A.M. Eastern Time. Following the presentation, Michael Sturmer, Progyny's President, and Mark Livingston, Progyny's Chief Financial Officer, will join Mr. Anevski for a breakout session.
  • 01/05/2022

Is Progyny a good buy opportunity at the current share price?

  • Progyny, Inc (NASDAQ: PGNY) shares have weakened more than 20% since November 05, even though the company reported strong third-quarter results. Management expects a further business acceleration Progyny is a company that specializes in fertility and family building benefits solutions for employers in the United States by the combination of clinical and emotional support.
  • 12/27/2021

Progyny (PGNY) Soars to 52-Week High, Time to Cash Out?

  • Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 11/08/2021

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2021 Results - Earnings Call Transcript

  • Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2021 Results - Earnings Call Transcript
  • 11/04/2021

Progyny (PGNY) Q3 Earnings Beat Estimates

  • Progyny (PGNY) delivered earnings and revenue surprises of 142.86% and -2.39%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 11/04/2021

Progyny: Continued Profitable Growth, Formidable Brand Point To Exciting Upside

  • Progyny: Continued Profitable Growth, Formidable Brand Point To Exciting Upside
  • 10/20/2021

Despite A 25% Rise In A Month Progyny Stock May Continue To See Higher Levels

  • The stock price of Progyny (NASDAQ: PGNY), a benefits management company that specializes in fertility and family building benefits solutions, has seen a rise of around 25% over the last month (twenty-one trading days), while it has more than doubled over the last twelve months.
  • 09/17/2021

Progyny, Inc. to Present at the BofA Global Healthcare Conference

  • NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021 at 10:55 A.M. Eastern Time, or 3:55 P.M. British Summer Time.
  • 09/10/2021

Why This Ultra-High-Growth Healthcare Stock Is a Buy

  • When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.
  • 09/04/2021

5 Medical Services Stocks Countering Industry Headwinds

  • The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most.
  • 09/01/2021

Progyny's (PGNY) CEO David Schlanger on Q2 2021 Results - Earnings Call Transcript

  • Progyny's (PGNY) CEO David Schlanger on Q2 2021 Results - Earnings Call Transcript
  • 08/08/2021

Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference

  • NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, will participate in a fireside chat at the BofA Securities SMID Cap 2H21 Ideas Conference on Tuesday, August 10, 2021 at 1:00 P.M. Eastern Time.
  • 08/06/2021

Progyny's Stock Is Getting Hammered On Mixed Q2 Earnings; Outlook Lagging Street Consensus

  • Progyny Inc (NASDAQ: PGNY) reported Q2 EPS of $0.19, a turnaround from EPS loss of $(0.01) a year ago, edging out analysts' average expectation of $0.08. Sales almost doubled to $128.6 million but missed the consensus of $129.31 million, primarily due to increased clients and covered lives.
  • 08/06/2021

Progyny: Q2 Earnings Insights

  • Shares of Progyny (NASDAQ:PGNY) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 1050.00% over the past year to $0.19, which beat the estimate of $0.08.
  • 08/05/2021

Progyny Grew 127% In The Last Year And Still Has Room To Run

  • Progyny Grew 127% In The Last Year And Still Has Room To Run
  • 07/27/2021

Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report

  • NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2021 after the close of the market on Thursday, August 5, 2021.
  • 07/22/2021

Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade

  • Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
  • 07/22/2021

Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy?

  • Progyny (PGNY) has been struggling lately, but the selling pressure may be coming to an end soon.
  • 07/13/2021

7 Must-See Stock Charts That Spell More Upside

  • Despite the strong rally in U.S. stocks, there has been volatility too. Here are the seven best stock charts that could spell more upside.
  • 07/09/2021

I'm selling Progyny this week [June 24th], and this is why!

  • Progyny, Inc (NASDAQ: PGNY) shares have advanced more than  40% since the beginning of January 2021, and the current share price stands around $59. Progyny expects adjusted EBITDA between $70 million to $75 million for the  2021 fiscal year, but even this doesn't justify its current stock price.
  • 06/23/2021

Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy

  • Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 06/23/2021

Progyny's (PGNY) Shares March Higher, Can It Continue?

  • As of late, it has definitely been a great time to be an investor in Progyny, Inc. (PGNY)
  • 06/10/2021

Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

  • NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 3:50 P.M. Eastern Time.
  • 06/04/2021

Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy?

  • Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
  • 06/02/2021

Welltok Welcomes Maven and Progyny to its Connect Ecosystem Family

  • DENVER, May 19, 2021 /PRNewswire/ -- Family planning and fertility benefits are becoming more mainstream with employers seeking to demonstrate inclusivity and attract or retain talent. As women become mothers later in their career and same-sex couples or single people seek to have children, there has been greater interest and expectations for these benefits.
  • 05/19/2021

Progyny, Inc. (PGNY) CEO David Schlanger on Q1 2021 Results - Earnings Call Transcript

  • Progyny, Inc. (PGNY) CEO David Schlanger on Q1 2021 Results - Earnings Call Transcript
  • 05/10/2021

Progyny, Inc. to Present at the BofA Securities 2021 Health Care Conference

  • NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 10:15 A.M. Eastern Time.
  • 05/07/2021

Progyny (PGNY) Q1 Earnings and Revenues Surpass Estimates

  • Progyny (PGNY) delivered earnings and revenue surprises of 87.50% and 0.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 05/06/2021

Progyny, Inc. Announces First Quarter 2021 Results

  • Reports Record First Quarter Revenue of $122.1 Million, Reflecting 51% GrowthIssues Revenue Guidance of $126.0 to $131.0 Million for the Second Quarter of 2021, Reflecting Growth of 95% to 103%Continues to Demonstrate Leverage in Operating Model Through Increased Profitability
  • 05/06/2021

Progyny, Inc. Announces Details for Its First Quarter 2021 Results Report

  • NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2021 after the close of the market on Thursday, May 6, 2021.
  • 04/22/2021

Benefits Manager Progyny Grows Even As Covid Upends Fertility Treatments

  • When the coronavirus pandemic blanketed the U.S. last year, couples put off pregnancy plans. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
  • 04/16/2021

PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600

  • NEW YORK, April 15, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20: S&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400. Siemens Healthineers AG (XETR: SHL) acquired Varian Medical Systems Inc. in a deal that closed today, April 15.
  • 04/15/2021

3 Stock Picks With High Returns on Equity

  • When a company's return on equity ratio tops most of its competitors, it indicates the company has been very efficient in generating earnings.
  • 04/14/2021

Top Stocks To Buy This Month Amid Optimistic Markets

  • Netflix and Facebook are among the top stocks for April. Q.ai's Artificial Intelligence has also dug up top tech stocks, top consumer stocks, top quality value stocks, and top growth stocks.
  • 04/07/2021

Top Stocks To Short Today As Major Indices Trade In The Red

  • Amid real potential for another sell-off, the deep learning algorithms at Q.ai have crunched the data to give you top shorts for today.
  • 03/25/2021

Top Stocks To Short Today As Investors Buckle Up For Bond Yields

  • Growth stocks opened the day with significant losses as the 10-year yield climbed to its highest level since last January. But Q.ai's deep learning algorithms have assessed the data to bring you today's best short plays.
  • 03/18/2021

Top Stocks To Short Today As The Fed Keeps Investors On Their Toes

  • Although the Dow Jones gained 40 points, the S&P 500 fell 0.4%, and the Nasdaq dropped 1.1%. Q.ai's deep learning algorithms are here to help you make the most of this market with today's best short plays.
  • 03/17/2021

Top Stocks To Short Today As Market Struggles To Reverse Losing Streak

  • Stocks have dropped again due to bond yields. In the meantime, Q.ai's Artificial Intelligence has assessed the data to bring you today's best short plays.
  • 03/04/2021

Progyny, Inc. (PGNY) CEO David Schlanger on Q4 2020 Results - Earnings Call Transcript

  • Progyny, Inc. (PGNY) CEO David Schlanger on Q4 2020 Results - Earnings Call Transcript
  • 02/24/2021

Progyny, Inc. Announces Fourth Quarter and Full Year 2020 Results

  • Reports Record Fourth Quarter Revenue of $100.3 MillionIssues Revenue Guidance of $520.0 to $540.0 Million for 2021, Reflecting Growth of 51% to 57%
  • 02/24/2021

2 High-Growth Stocks in the Market Today

  • Why these two stocks are strong buys.
  • 02/22/2021

Progyny, Inc. to Participate at the 10th Annual SVB Leerink Global Healthcare Conference

  • NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, and Mark Livingston, Progyny's Chief Financial Officer, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8:40 A.M. Eastern Time.
  • 02/22/2021

3 Healthcare Stocks I'd Buy Right Now

  • Two innovative small companies with scorching growth and one bargain biotech.
  • 02/15/2021

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year Results Report

  • NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31, 2020 after the close of the market on Wednesday, February 24, 2021.
  • 02/10/2021

Here's Why Investors Should Put Progyny on Their Radar

  • This fertility stock could have serious long-term potential.
  • 01/20/2021

5 Top Stock Trades for Tuesday: NIO, FIVN, TLRY, PGNY, BB

  • Nio, BlackBerry, Tilray, Five9 and Progyny were our top stock trades for Tuesday. Let's check out the charts after a long holiday weekend.
  • 01/19/2021

Progyny Strengthens Board of Directors with Appointments of Healthcare and Technology Leaders

  • NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the appointment of two new members to its board of directors, effective November 16, 2020. Joining the board are Malissia R. Clinton, Senior Vice President, General Counsel, and Secretary of The Aerospace Corporation and Roger Holstein, Managing Director of Vestar Capital Partners.
  • 11/18/2020

Progyny, Inc. Announces Participation at the Piper Sandler Healthcare Conference

  • NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny's Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference.
  • 11/16/2020

Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript

  • Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript
  • 11/08/2020

Progyny Grows Business But Stock May Be Priced For Perfection

  • Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States.
  • 11/06/2020

Progyny (PGNY) Q3 Earnings Meet Estimates

  • Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 11/05/2020

Progyny: Q3 Earnings Insights

  • Shares of Progyny (NASDAQ:PGNY) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.67% over the past year to $0.05, which were in line with the estimate of $0.05.
  • 11/05/2020
Unlock
PGNY Ratings Summary
PGNY Quant Ranking